K Number
K023725
Device Name
HEMORRHAGE OCCLUDER PIN (HOP), MODEL 337-247
Date Cleared
2003-02-03

(89 days)

Product Code
Regulation Number
878.4750
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
THE HEMORRHAGE OCCLUDER PIN IS INDICATED TO BE USED TO STOP MASSIVE PRESACRAL HEMORRHAGE DURING SURGERY
Device Description
HEMORRHAGE OCCLUDER PIN (HOP) is of 7mm length and 8mm pinhead. It is made out of medical grade Titanium suitable for implantation.
More Information

Not Found

No
The summary describes a simple mechanical device made of titanium and does not mention any software, algorithms, or data processing that would indicate AI/ML.

Yes
The device is indicated to stop massive presacral hemorrhage during surgery, which is a therapeutic intervention.

No
The device is described as an implantable pin to stop hemorrhage during surgery, which is a treatment, not a diagnostic function.

No

The device description explicitly states it is a physical pin made of titanium, indicating it is a hardware device, not software.

Based on the provided information, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • Intended Use: The intended use is to "STOP MASSIVE PRESACRAL HEMORRHAGE DURING SURGERY". This describes a direct intervention on a patient's body to treat a condition.
  • Device Description: The device is a physical pin made of titanium, designed for implantation.
  • Lack of IVD Characteristics: IVD devices are used to examine specimens (like blood, urine, tissue) outside the body to provide information about a patient's health. This device does not involve the analysis of specimens.

Therefore, the Hemorrhage Occluder Pin is a surgical device intended for direct use on a patient, not an in vitro diagnostic device.

N/A

Intended Use / Indications for Use

"THE HEMORRHAGE OCCLUDER PIN IS INDICATED TO BE USED TO STOP MASSIVE PRESACRAL HEMORRHAGE DURING SURGERY"

Product codes (comma separated list FDA assigned to the subject device)

GDW

Device Description

"HEMORRHAGE OCCLUDER PIN (HOP) is of 7mm length and 8mm pinhead. It is made out of medical grade Titanium suitable for implantation."

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

"presacral"

Indicated Patient Age Range

Not Found

Intended User / Care Setting

"during surgery"

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

Not Found

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.

K890447

Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).

Not Found

§ 878.4750 Implantable staple.

(a)
Identification. An implantable staple is a staple-like device intended to connect internal tissues to aid healing. It is not absorbable.(b)
Classification. Class II.

0

K023725

FEB 0 3 2003

510(k) Summary As Required by 21 section 807.92 ( c )

1-Submitter Name:Mansour Consulting LLC
2-Address:1308 Morningside Park Dr
Alpharetta, GA 30022 USA
3-Phone:(678) 908-8180
4-Fax:(425) 795-9341
5-Contact Person:Jay Mansour
6-Date summary prepared:November 1st, 2002
7-Device Trade or Proprietary Name:HEMORRHAGE OCCLUDER PIN (HOP)
8-Device Common or usual name:Implantable Staple
9-Device Classification Name:Staple, Implantable
10-Substantial Equivalency is claimed against the following device:
• Hemorrhage Occludor from Surgeon Surgical Instrumentation, Inc.

11-Description of the Device:

HEMORRHAGE OCCLUDER PIN (HOP) is of 7mm length and 8mm pinhead. It is made out of medical grade Titanium suitable for implantation.

12-Intended use of the device:

This device is indicated to be used to stop massive presacral hemorrhage during surgery.

13-Safety and Effectiveness of the device:

This device is safe and effective as the other predicate device cited above. This is better expressed in the tabulated comparison (Paragraph 14 below)

14-Summary comparing technological characteristics with other predicate device:

Please find below a tabulated comparison supporting that this device is substantially equivalent to other medical devices in commercial distribution. Also, Equivalency overview chart path is attached.

5 of 6

1

Image /page/1/Picture/1 description: The image is a black and white emblem for the U.S. Department of Health & Human Services. The emblem features a stylized eagle with three wing segments, symbolizing health, services, and people. The eagle is encircled by the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" in a circular arrangement.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

FEB 0 3 2003

Marina Medical Instruments, Inc. c/o Jay Mansour Mansour Consulting LLC 1308 Morningside Park Drive Alpharetta, Georgia 30022

Re: K023725

Trade Name: Hemorrhage Occluder Pin (HOP) Regulation Number: 21 CFR 878.4750 Regulation Name: Implantable Staple Regulatory Class: II Product Code: GDW Dated: November 1, 2002 Received: November 6, 2002

Dear Mr. Mansour:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

2

Page 2 - Mr. Jay Mansour

This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (301) 594-4659. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html

Sincerely yours,

Miriam C. Provost

to( Celia M. Witten, Ph.D., M.D. Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

3

Page 1 of

510(k) Number (if known): K023725

Device Name: HEMORRHAGE OCCLUDER PIN

Indications For Use:

THE HEMORRHAGE OCCLUDER PIN IS INDICATED

TO BE USED TO STOP MASSIVE PRESACRAL

HEMORRHAGE DURING SURGERY

(PLEASIE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER P/ NEEDED)

ાર

Concurrence of CDRH, Office of Device Evaluation (ODE)

Miriam C. Provost
(Division Sign-Off)

vision of General, Restorative id Neurological Devices

K023725

Prescription Use
(Per 21 CFR 801.109)

Over-The-Counter Use

(Optional Forma

(6) of (6)